Tumor quantification of several fluoropyrimidines resistance gene expression with a unique quantitative RT-PCR method. Implications for pretherapeutic determination of tumor resistance phenotype.

[1]  L. Saltz,et al.  Adjuvant Therapy of Colon Cancer: Current Status and Future Directions , 2007, Cancer journal.

[2]  A. B. Kuilenburg,et al.  Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil. , 2004 .

[3]  P. Johnston,et al.  Characterization of p53 Wild-Type and Null Isogenic Colorectal Cancer Cell Lines Resistant to 5-Fluorouracil, Oxaliplatin, and Irinotecan , 2004, Clinical Cancer Research.

[4]  T. Nagayasu,et al.  Tumor dihydropyrimidine dehydrogenase in stage II and III colorectal cancer: low level expression is a beneficial marker in oral-adjuvant chemotherapy, but is also a predictor for poor prognosis in patients treated with curative surgery alone. , 2004, Cancer letters.

[5]  C. Spears,et al.  Altered gene expression of folate enzymes in adjacent mucosa is associated with outcome of colorectal cancer patients. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[6]  J. Bertino,et al.  Reduced Folate Carrier and Dihydrofolate Reductase Expression in Acute Lymphocytic Leukemia May Predict Outcome: A Children's Cancer Group Study , 2003, Journal of pediatric hematology/oncology.

[7]  M. Fukushima,et al.  Gene expression in colorectal cancer and in vitro chemosensitivity to 5‐fluorouracil: A study of 88 surgical specimens , 2003, Cancer science.

[8]  P. Johnston,et al.  5-Fluorouracil: mechanisms of action and clinical strategies , 2003, Nature Reviews Cancer.

[9]  W. Ichikawa,et al.  Combination of dihydropyrimidine dehydrogenase and thymidylate synthase gene expressions in primary tumors as predictive parameters for the efficacy of fluoropyrimidine-based chemotherapy for metastatic colorectal cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[10]  Kazuhiro Yoshida,et al.  Gender differences in the dihydropyrimidine dehydrogenase expression of colorectal cancers. , 2002, Cancer letters.

[11]  M. Fukushima,et al.  Quantitative Measurement of Thymidylate Synthase and Dihydropyrimidine Dehydrogenase mRNA Level in Gastric Cancer by Real‐time RT‐PCR , 2002, Japanese journal of cancer research : Gann.

[12]  K. Isshi,et al.  Predicting 5-FU sensitivity using human colorectal cancer specimens: comparison of tumor dihydropyrimidine dehydrogenase and orotate phosphoribosyl transferase activities with in vitro chemosensitivity to 5-FU , 2002, International Journal of Clinical Oncology.

[13]  D. Cunningham,et al.  Adjuvant therapy in colon cancer: current status and future directions. , 2002, Cancer treatment reviews.

[14]  Sang-Woon Choi,et al.  Folate status: effects on pathways of colorectal carcinogenesis. , 2002, The Journal of nutrition.

[15]  A. Moorman,et al.  Sensitivity and accuracy of quantitative real-time polymerase chain reaction using SYBR green I depends on cDNA synthesis conditions. , 2002, Analytical biochemistry.

[16]  G. Peters,et al.  Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. , 2002, Biochimica et biophysica acta.

[17]  D. Sargent,et al.  Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  T. Kovács,et al.  Prognostic Significance of the Thymidylate Biosynthetic Enzymes in Human Colorectal Tumors , 2002, Oncology.

[19]  S. Monfardini,et al.  Thymidylate Synthase expression as a predictor of clinical response to fluoropyrimidine-based chemotherapy in advanced colorectal cancer. , 2002, Cancer treatment reviews.

[20]  J. Stein,et al.  Folate and chemoprevention of colorectal cancer: Is 5-methyl-tetrahydrofolate an active antiproliferative agent in folate-treated colon-cancer cells? , 2001, Nutrition.

[21]  N. Kaibara,et al.  Dihydropyrimidine dehydrogenase activity of cancerous and non-cancerous tissues in liver and large intestine. , 2001, Oncology reports.

[22]  P. Morel,et al.  Evaluation of standard tyrosinase RT-PCR in melanoma patients by the use of the LightCycler system. , 2001, Clinica chimica acta; international journal of clinical chemistry.

[23]  J. -. Park,et al.  Establishment and characterization of 5-fluorouracil-resistant gastric cancer cells. , 2000, Cancer letters.

[24]  C. Wilson,et al.  Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  N. Suzuki,et al.  Different mechanisms of acquired resistance to fluorinated pyrimidines in human colorectal cancer cells. , 2000, International journal of oncology.

[26]  David Joseph,et al.  Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer , 2000, The Lancet.

[27]  S. Groshen,et al.  Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[28]  R. James,et al.  Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial , 2000, The Lancet.

[29]  F. Sarkar,et al.  Folic acid inhibition of EGFR-mediated proliferation in human colon cancer cell lines. , 1999, American journal of physiology. Cell physiology.

[30]  J. Winer,et al.  Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. , 1999, Analytical biochemistry.

[31]  R M Mader,et al.  Resistance to 5-fluorouracil. , 1998, General pharmacology.

[32]  J. Sludden,et al.  Characterization of dihydropyrimidine dehydrogenase in human colorectal tumours. , 1998, British Journal of Cancer.

[33]  R. Jakesz,et al.  Transcription and activity of 5-fluorouracil converting enzymes in fluoropyrimidine resistance in colon cancer in vitro. , 1997, Biochemical pharmacology.

[34]  H. Blomgren,et al.  Immunohistochemical determination of thymidylate synthase in colorectal cancer--methodological studies. , 1997, European journal of cancer.

[35]  S. Groshen,et al.  Quantitation of intratumoral thymidylate synthase expression predicts for disseminated colorectal cancer response and resistance to protracted-infusion fluorouracil and weekly leucovorin. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  O. Dassonville,et al.  Tumoral-reduced folates and clinical resistance to fluorouracil-based treatment in head and neck cancer patients. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  C. Létoublon,et al.  Decreased folylpolyglutamate synthetase activity in tumors resistant to fluorouracil-folinic acid treatment: clinical data. , 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

[38]  P. Johnston,et al.  Thymidylate synthase gene and protein expression correlate and are associated with response to 5-fluorouracil in human colorectal and gastric tumors. , 1995, Cancer research.

[39]  C. P. Spears.  Clinical resistance to antimetabolites. , 1995, Hematology/oncology clinics of North America.

[40]  J. Bertino,et al.  Decreased folylpolyglutamate synthetase expression: a novel mechanism of fluorouracil resistance. , 1993, Cancer research.

[41]  M. Brownstein,et al.  Molecular cloning and expression of a rat Via arginine vasopressin receptor , 1992, Nature.

[42]  H. Shibata,et al.  The changes in the levels of dihydrofolate reductase mRNA and its gene dosage in 5-fluorouracil-resistant L1210 cells. , 1990, The Tohoku journal of experimental medicine.

[43]  T. Kao,et al.  Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. , 1985, Nucleic acids research.

[44]  A. V. van Kuilenburg.  Dihydropyrimidine dehydrogenase and the efficacy and toxicity of 5-fluorouracil. , 2004, European journal of cancer.

[45]  Young-In Kim.  Folate, colorectal carcinogenesis, and DNA methylation: Lessons from animal studies , 2004, Environmental and molecular mutagenesis.

[46]  A. Paradiso,et al.  Thymidilate synthase and p53 primary tumour expression as predictive factors for advanced colorectal cancer patients , 2000, British Journal of Cancer.